PPTA Twitter

PlasmaProteins
PlasmaProteins Approximately how many #plasma donation centers are there in the U.S.?
2 days ago.
PlasmaProteins
PlasmaProteins . @PlasmaProteins is at #IDF2019NC this week, showing our support for individuals living with PI. @IDFCommunity is a wonderful #AdvocateForPPTs and works tirelessly to improve the diagnosis, treatment, and quality of life for those living with PI! bit.ly/2QF6N1B
4 days ago.

PPTA Co-Sponsors Public Workshop

On Sept. 17-18, 2015, PPTA co-sponsored a U.S. Food and Drug Administration (FDA) public workshop, New Methods to Predict the Immunogenicity of Therapeutic Coagulation Proteins, with the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute and the National Hemophilia Foundation, on the NIH campus in Bethesda, Maryland, USA.

The workshop focused on genetic determinants of immunogenicity, uses of genetic information, preclinical assessments of immunogenicity, studies of previously untreated patients, and immune tolerance induction, and followed a European Medicines Agency workshop on hemophilia registries on July 1-2, 2015, in London, UK. The workshop agenda was developed by a steering committee comprised of the co-sponsors (including PPTA) and other stakeholders, and included presentations and panel discussions by PPTA, member and non-member companies, regulators, patient advocates, and clinicians.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100